About: Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.40 (+0.72%)
ENVB NASDAQ Enveric Biosciences Inc
Enveric Biosciences Inc share price
ENVB price activity
Last Price
$1.400
Change (24hr)
0.01 USD (0.72%)
Volume
14.73K
Volume (4w avg)
-
Open
$1.35
Day Range
$1.35 - $1.40
Previous Close
$1.39
Last Trade
16 Oct, 5:35 pm GMT+0
Delayed
16 Oct, 5:35 pm GMT+0
ENVB price performance
Delayed
16 Oct, 5:35 pm GMT+0
ENVB Market Signals